论文部分内容阅读
探讨动静脉联合溶栓在超早期急性缺血性卒中治疗中的临床效果。从收治的超早期急性缺血性卒中患者中选取10例为A组,行动静脉联合溶栓治疗,另选同期该症患者10例为B组,行超选择性动脉溶栓治疗,10例为C组,行静脉溶栓治疗,观察三组治疗效果及治疗后不同时间段改良rankin量表评分情况。A组治疗总有效率为90.00%,明显高于其他两组,A治疗后1、15、30、60d改良rankin量表评分均明显优于其他两组,差异具有统计学意义(P<0.05)。在超早期急性缺血性卒中患者治疗中,采用动静脉联合溶栓疗法,能有效提高治疗效果,改善神经功能,促进患者恢复,值得临床推广应用。
To investigate the clinical effect of combined arteriovenous thrombolysis in the treatment of ultra-early acute ischemic stroke. From the early treatment of acute ischemic stroke patients were selected in 10 patients were treated with intravenous thrombolytic therapy in group A, the other 10 patients with the same period in the group B, with selective arterial thrombolysis, 10 patients were Group C, intravenous thrombolytic therapy was used to observe the therapeutic effects of the three groups and improve the rankin rank scores at different time points after treatment. The total effective rate of treatment group A was 90.00%, which was significantly higher than the other two groups. The scores of modified rankin scale 1,15,30,60d after A treatment were significantly better than the other two groups (P <0.05) . In the treatment of patients with ultra-early acute ischemic stroke, the combination of arteriovenous and thrombolytic therapy can effectively improve the therapeutic effect, improve neurological function and promote the recovery of patients, which is worthy of clinical application.